Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Streit

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Journal of Global Antimicrobial Resistance|October 17, 2020
Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014-2019)Dee Shortridge, Michael A Pfaller, Jennifer M Streit, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 16, 2000
[Transitory acantholytic dermatosis (Grover disease). An analysis of the clinical spectrum based on 21 histologically assessed cases]M Streit, B E Paredes, L R Braathen, et al.
Pharmacy World & Science : PWS|September 14, 1999
Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancerS Stremetzne, M Streit, E D Kreuser, et al.
Diagnostic Microbiology and Infectious Disease|January 31, 2021
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018)Dee Shortridge, Cecilia G Carvalhaes, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents|August 4, 2004
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)Jennifer M Streit, Ronald N Jones, Helio S Sader, et al.
European Journal of Haematology|February 14, 2004
Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H)O Gautschi, N Blumenthal, M Streit, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 2005
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogensJennifer M Streit, Helio S Sader, Thomas R Fritsche, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|June 26, 2014
Micronutrient Needs of the ElderlyStephanie C Montgomery, Stephanie M Streit, Mara Lee Beebe, et al.
Jac-Antimicrobial Resistance|September 8, 2022
Five-year analysis of the <i>in vitro</i> activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programmeCecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolatesHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Journal of Global Antimicrobial Resistance|October 17, 2020
Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014-2019)Dee Shortridge, Michael A Pfaller, Jennifer M Streit, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 16, 2000
[Transitory acantholytic dermatosis (Grover disease). An analysis of the clinical spectrum based on 21 histologically assessed cases]M Streit, B E Paredes, L R Braathen, et al.
Pharmacy World & Science : PWS|September 14, 1999
Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancerS Stremetzne, M Streit, E D Kreuser, et al.
Diagnostic Microbiology and Infectious Disease|January 31, 2021
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018)Dee Shortridge, Cecilia G Carvalhaes, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents|August 4, 2004
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)Jennifer M Streit, Ronald N Jones, Helio S Sader, et al.
European Journal of Haematology|February 14, 2004
Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H)O Gautschi, N Blumenthal, M Streit, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 2005
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogensJennifer M Streit, Helio S Sader, Thomas R Fritsche, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|June 26, 2014
Micronutrient Needs of the ElderlyStephanie C Montgomery, Stephanie M Streit, Mara Lee Beebe, et al.
Jac-Antimicrobial Resistance|September 8, 2022
Five-year analysis of the <i>in vitro</i> activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programmeCecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolatesHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Pageof 13